Journal article
The Role of Omalizumab in the Treatment of Severe Allergic Asthma
Abstract
BACKGROUND: A novel anti-immunoglobulin E (anti-IgE) therapy for asthma, omalizumab, has been approved for use in Canada.
OBJECTIVE: To review the basic and clinical data for omalizumab, and to examine its possible role for asthma management in Canada.
Authors
Chapman KR; Cartier A; Hébert J; McIvor RA; Schellenberg RR
Journal
Canadian Respiratory Journal, Vol. 13, No. B, pp. 1b–9b
Publisher
Wiley
Publication Date
January 2006
DOI
10.1155/2006/279435
ISSN
1198-2241